ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      84.85
      0.00%
      Bitcoin
      61,530.92
      1.05%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Cellect Biotechnology Ltd (APOP)

      7. Cellect Biotechnology Ltd (APOP) News

      APOP

      Cellect Biotechnology (APOP)

      Cellect Biotechnology Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:APOP
      DateTimeSourceHeadlineSymbolCompany
      02/01/201811:43AMPR Newswire (US)Frost & Sullivan Publishes an Update Report on Cellect Biotechnology Ltd.: Capital raising of $4M will support the company's ...NASDAQ:APOPCellect Biotechnology Ltd
      02/01/20189:44AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:APOPCellect Biotechnology Ltd
      01/31/20187:55AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:APOPCellect Biotechnology Ltd
      01/31/20187:51AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      01/29/20188:02AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      01/29/20188:00AMPR Newswire (US)Cellect Biotechnology Announces $4 Million Registered Direct OfferingNASDAQ:APOPCellect Biotechnology Ltd
      01/16/20187:03AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      01/16/20187:00AMPR Newswire (US)Cellect Announces Opening of a Second Clinical Trial Site and Approval from Safety Board (DSMB) for Dose EscalationNASDAQ:APOPCellect Biotechnology Ltd
      01/04/20187:57AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      01/04/20187:45AMPR Newswire (US)Cellect Announces Breakthrough Clinical ResultsNASDAQ:APOPCellect Biotechnology Ltd
      12/28/20174:36PMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1)NASDAQ:APOPCellect Biotechnology Ltd
      12/14/20174:32PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      11/28/20174:32PMEdgar (US Regulatory)Amended Report of Foreign Issuer (6-k/a)NASDAQ:APOPCellect Biotechnology Ltd
      11/22/20177:01AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      11/22/20177:00AMPR Newswire (US)Cellect Biotechnology Ltd Provides Corporate Update and Reports Third Quarter 2017 Financial ResultsNASDAQ:APOPCellect Biotechnology Ltd
      11/10/20177:00AMPR Newswire (US)Cellect CEO, Dr. Shai Yarkoni Selected as Keynote Speaker at the 11th World Congress of Regenerative Medicine & Stem Cell in ...NASDAQ:APOPCellect Biotechnology Ltd
      11/07/20174:31PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      11/02/20178:31AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      10/31/20178:58AMPR Newswire (US)Cellect Chosen Among Selected Global Leaders Presenting at Bio-Europe 2017 Conference Addressing over 3,800 Industry Speciali...NASDAQ:APOPCellect Biotechnology Ltd
      10/25/20177:11AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      10/25/20177:00AMPR Newswire (US)Cellect Announces a Major Breakthrough of its ApoGraft™ Technology: Reporting Today Positive Results from a 20 Patients Tri...NASDAQ:APOPCellect Biotechnology Ltd
      10/19/20177:13AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      10/19/20177:05AMPR Newswire (US)Cellect Appoints Dr. Ronit Bakimer-Kleiner as Chief Development OfficerNASDAQ:APOPCellect Biotechnology Ltd
      09/19/20174:32PMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:APOPCellect Biotechnology Ltd
      09/08/20176:07AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      09/07/20175:22PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:APOPCellect Biotechnology Ltd
      09/07/20179:42AMPR Newswire (US)Cellect Biotechnology Announces $4.3 Million Raise in a Registered Direct OfferingNASDAQ:APOPCellect Biotechnology Ltd
      09/05/20177:12AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:APOPCellect Biotechnology Ltd
      09/05/20177:02AMPR Newswire (US)FDA Grants Orphan Drug Status to Cellect's ApoGraft™ for Acute GvHD and Chronic GvHDNASDAQ:APOPCellect Biotechnology Ltd
      09/01/20177:02AMPR Newswire (US)Cellect Shares Will Be Traded From Next Week Exclusively on NASDAQNASDAQ:APOPCellect Biotechnology Ltd
       Showing the most relevant articles for your search:NASDAQ:APOP